KEGG   PATHWAY: aml04650
Entry
aml04650                    Pathway                                
Name
Natural killer cell mediated cytotoxicity - Ailuropoda melanoleuca (giant panda)
Description
Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class
Organismal Systems; Immune system
Pathway map
aml04650  Natural killer cell mediated cytotoxicity
aml04650

Other DBs
GO: 0042267
Organism
Ailuropoda melanoleuca (giant panda) [GN:aml]
Gene
100462659  IFNG; interferon gamma precursor [KO:K04687]
100463573  TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721]
100463775  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
100463836  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
100464009  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
100464196  NRAS; GTPase NRas [KO:K07828]
100464420  [KO:K01353] [EC:3.4.21.79]
100464798  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X4 [KO:K17332]
100465439  BID; BH3-interacting domain death agonist isoform X1 [KO:K04726]
100465648  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100465700  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
100465824  SH3BP2; SH3 domain-binding protein 2 [KO:K07984]
100467378  NCR3; natural cytotoxicity triggering receptor 3 isoform X1 [KO:K06743]
100467653  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X5 [KO:K04348] [EC:3.1.3.16]
100467683  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
100467916  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
100468080  SHC3; SHC-transforming protein 3 [KO:K17448]
100468235  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
100468867  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
100468916  GRB2; growth factor receptor-bound protein 2 isoform X1 [KO:K04364]
100468971  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
100469056  CASP3; caspase-3 isoform X1 [KO:K02187] [EC:3.4.22.56]
100469346  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
100469737  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
100470035  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
100470524  SH2D1A; SH2 domain-containing protein 1A [KO:K07990]
100470861  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X2 [KO:K04446]
100470931  FYN; tyrosine-protein kinase Fyn isoform X1 [KO:K05703] [EC:2.7.10.2]
100471152  [KO:K07293] [EC:3.1.3.48]
100471563  TNF; tumor necrosis factor [KO:K03156]
100472388  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
100472811  PAK1; serine/threonine-protein kinase PAK 1 [KO:K04409] [EC:2.7.11.1]
100473238  [KO:K07360] [EC:2.7.10.2]
100473502  [KO:K05427]
100473539  PTPN6; tyrosine-protein phosphatase non-receptor type 6 isoform X1 [KO:K05697] [EC:3.1.3.48]
100473675  PRF1; perforin-1 [KO:K07818]
100473767  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
100473768  IFNGR1; interferon gamma receptor 1 [KO:K05132]
100473836  HRAS; GTPase HRas isoform X1 [KO:K02833]
100474155  LAT; linker for activation of T-cells family member 1 isoform X2 [KO:K07362]
100474396  SOS2; son of sevenless homolog 2 isoform X9 [KO:K03099]
100474543  SYK; tyrosine-protein kinase SYK isoform X1 [KO:K05855] [EC:2.7.10.2]
100474729  ICAM2; intercellular adhesion molecule 2 isoform X2 [KO:K06523]
100474742  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
100474970  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X5 [KO:K04348] [EC:3.1.3.16]
100475137  SHC4; SHC-transforming protein 4 isoform X2 [KO:K17449]
100475291  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
100475955  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
100476091  VAV1; proto-oncogene vav isoform X3 [KO:K05730]
100476162  NCR1; natural cytotoxicity triggering receptor 1 isoform X1 [KO:K06741]
100476475  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
100476556  IFNB1; interferon beta [KO:K05415]
100476812  [KO:K05414]
100477178  CD48; CD48 antigen [KO:K06479]
100477289  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
100477312  [KO:K05414]
100477326  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
100477562  [KO:K05414]
100477572  TYROBP; TYRO protein tyrosine kinase-binding protein isoform X2 [KO:K07992]
100477981  LCK; tyrosine-protein kinase Lck isoform X2 [KO:K05856] [EC:2.7.10.2]
100478007  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
100478039  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100478068  [KO:K05414]
100478321  [KO:K05414]
100478771  [KO:K06541]
100478801  PTK2B; protein-tyrosine kinase 2-beta isoform X1 [KO:K05871] [EC:2.7.10.2]
100479023  [KO:K06541]
100479279  [KO:K06541]
100479294  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
100479524  [KO:K06541]
100479580  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922] [EC:2.7.1.153]
100479772  KLRK1; NKG2-D type II integral membrane protein isoform X1 [KO:K06728]
100480092  VAV2; guanine nucleotide exchange factor VAV2 [KO:K05730]
100480126  VAV3; guanine nucleotide exchange factor VAV3 [KO:K05730]
100480586  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X2 [KO:K01116] [EC:3.1.4.11]
100480679  SH2D1B; SH2 domain-containing protein 1B [KO:K07989]
100480694  SHC2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447]
100480856  SHC1; SHC-transforming protein 1 isoform X2 [KO:K06279]
100481672  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
100481921  IFNAR1; interferon alpha/beta receptor 1 [KO:K05130]
100481923  [KO:K06463]
100481961  FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983]
100481994  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859] [EC:3.1.4.11]
100482255  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
100482526  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
100482679  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
100483828  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
100483919  KRAS; GTPase KRas isoform X1 [KO:K07827]
100484264  ITGB2; integrin beta-2 isoform X1 [KO:K06464]
100484298  CD247; T-cell surface glycoprotein CD3 zeta chain [KO:K06453]
100484719  PRKCG; protein kinase C gamma type isoform X1 [KO:K19663] [EC:2.7.11.13]
105234734  KLRD1; natural killer cells antigen CD94 isoform X1 [KO:K06516]
105235183  [KO:K04722]
105235489  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
105238006  LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356]
105238200  [KO:K07986]
105238405  HCST; hematopoietic cell signal transducer isoform X1 [KO:K07988]
105241798  [KO:K06541]
105241802  CD244; natural killer cell receptor 2B4 [KO:K06582]
109488324  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
117803402  [KO:K06453]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C01245  D-myo-Inositol 1,4,5-trisphosphate
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Chiesa S, Tomasello E, Vivier E, Vely F.
  Title
Coordination of activating and inhibitory signals in natural killer cells.
  Journal
Mol Immunol 42:477-84 (2005)
DOI:10.1016/j.molimm.2004.07.030
Reference
  Authors
Maghazachi AA.
  Title
Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  Journal
Pharmacol Rev 57:339-57 (2005)
DOI:10.1124/pr.57.3.5
Reference
  Authors
Vivier E, Nunes JA, Vely F.
  Title
Natural killer cell signaling pathways.
  Journal
Science 306:1517-9 (2004)
DOI:10.1126/science.1103478
Reference
  Authors
Colucci F, Di Santo JP, Leibson PJ.
  Title
Natural killer cell activation in mice and men: different triggers for similar weapons?
  Journal
Nat Immunol 3:807-13 (2002)
DOI:10.1038/ni0902-807
Reference
  Authors
Perussia B.
  Title
Signaling for cytotoxicity.
  Journal
Nat Immunol 1:372-4 (2000)
DOI:10.1038/80808
Reference
  Authors
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  Title
Activation of NK cell cytotoxicity.
  Journal
Mol Immunol 42:501-10 (2005)
DOI:10.1016/j.molimm.2004.07.034
Reference
  Authors
Djeu JY, Jiang K, Wei S.
  Title
A view to a kill: signals triggering cytotoxicity.
  Journal
Clin Cancer Res 8:636-40 (2002)
Reference
  Authors
Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  Title
Nature's TRAIL--on a path to cancer immunotherapy.
  Journal
Immunity 18:1-6 (2003)
DOI:10.1016/S1074-7613(02)00502-2
Reference
  Authors
Colonna M.
  Title
Fine-tuning NK cell responses: it's a family affair.
  Journal
Nat Immunol 6:961-2 (2005)
DOI:10.1038/ni1005-961
Reference
PMID:8942070
  Authors
Bonnema JD, Leibson PJ.
  Title
Signal transduction during NK cell activation.
  Journal
Chem Immunol 64:28-43 (1996)
Reference
  Authors
Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  Title
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  Journal
J Immunol 175:749-54 (2005)
DOI:10.4049/jimmunol.175.2.749
Reference
PMID:9143705
  Authors
Rao A, Luo C, Hogan PG.
  Title
Transcription factors of the NFAT family: regulation and function.
  Journal
Annu Rev Immunol 15:707-47 (1997)
DOI:10.1146/annurev.immunol.15.1.707
Reference
  Authors
Wu J, Lanier LL.
  Title
Natural killer cells and cancer.
  Journal
Adv Cancer Res 90:127-56 (2003)
DOI:10.1016/S0065-230X(03)90004-2
Reference
  Authors
Cerwenka A, Lanier LL.
  Title
Natural killer cells, viruses and cancer.
  Journal
Nat Rev Immunol 1:41-9 (2001)
DOI:10.1038/35095564
Reference
  Authors
Blott EJ, Griffiths GM.
  Title
Secretory lysosomes.
  Journal
Nat Rev Mol Cell Biol 3:122-31 (2002)
DOI:10.1038/nrm732
Reference
  Authors
Lieberman J.
  Title
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  Journal
Nat Rev Immunol 3:361-70 (2003)
DOI:10.1038/nri1083
Reference
  Authors
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  Title
Granzyme B: a natural born killer.
  Journal
Immunol Rev 193:31-8 (2003)
DOI:10.1034/j.1600-065X.2003.00044.x
Reference
  Authors
Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  Title
Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  Journal
Proc Natl Acad Sci U S A 102:123-7 (2005)
DOI:10.1073/pnas.0405737102
Reference
PMID:9862693
  Authors
Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  Title
Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  Journal
J Immunol 161:6648-56 (1998)
Reference
  Authors
Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  Title
Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  Journal
J Immunol 166:7219-28 (2001)
DOI:10.4049/jimmunol.166.12.7219
Related
pathway
aml04010  MAPK signaling pathway
aml04020  Calcium signaling pathway
aml04060  Cytokine-cytokine receptor interaction
aml04210  Apoptosis
aml04630  JAK-STAT signaling pathway
KO pathway
ko04650   

DBGET integrated database retrieval system